Avidity Biosciences, a biotech developing drugs that deliver bits of RNA and DNA to cells to treat disease, has signed its first strategic pharmaceutical partner.
Eli Lilly (NYSE: LLY) is... Read more »
Forge Therapeutics, founded in 2015 with the goal of developing drugs that target metalloenzymes, said Wednesday it had agreed to let Basilea Pharmaceutica use its chemistry platform to develop new antibiotics.... Read more »
ServiceNow, one of the most valuable software companies ever founded in San Diego, launched in 2003, before enterprise software-as-a-service became a topic of mainstream discussion.
Today’s tech landscape is dotted with... Read more »
[Updated 4/23/19 9:10 a.m. See below.] The race to bring CAR-T cell therapy to multiple myeloma, a persistent and deadly cancer of the bone marrow, continued on Monday with... Read more »
Turning Point Therapeutics raised more than $166 million in its IPO, pricing at the top of its range and putting nearly 2 million more shares into the public markets than it... Read more »
Wireless giant Qualcomm and smartphone maker Apple have been publicly feuding in courts around the globe, accusing one another of illegal business practices for more than two years.
On Tuesday, the... Read more »
Drug discovery startup Insitro burst onto the scene last year with ambitions of using machine learning techniques to find new therapies. Now the company has its first pharmaceutical partner. Gilead Sciences... Read more »
While fungal infections may seem like an annoyance rather than a serious health problem, sick people in hospitals and long-term care facilities are contracting potentially deadly infections that current treatments are... Read more »
Locally based biotech companies receive fresh funding from investors. A software startup launches games that it says may help children with disorders that cause attention difficulties. Get the details on these... Read more »
Financial firms are facing competition from legacy players and disruptive fintech startups as technology continues to reshape the heavily regulated industry.
Two financial firms are betting on a nonprofit incubator program... Read more »
—Mobile app startup Bitmo announced it had raised more than $3 million in seed funding from investors including Everplus Capital, Longboard Capital Advisors, and several Southern California-based family fund offices.
Bitmo’s... Read more »
A 25-person startup developing advanced computing tools to speed up pathology work has raised its first institutional financing from a group of investors led by Intel Capital, the corporate investment arm... Read more »
Contract research organization Charles River Labs is shutting down its San Diego-area operations, moving the work done there to one of its two Northern California sites.
In a filing with California’s... Read more »
To succeed as a CEO means having the fortitude to make the tough decisions that all companies face. Often, that means persevering in pursuit of a mission, whether that’s proving a... Read more »
What does it take for a tech startup to be considered “cool?” In the eyes of the San Diego Venture Group, the key element is readiness for venture capital backing.
It’s... Read more »
Kyriba has been making cloud-based software since well before software-as-a-service (SaaS) became a tech buzzword.
Nearly 20 years ago, the company, a spin-off of a French firm, began developing software to... Read more »
[Corrected 9:30 am PT. See below.] Biosensor startup Biolinq said Thursday it has raised $4.75 million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the... Read more »
Acadia Pharmaceuticals said it plans to advance a drug it licensed last year from Australia’s Neuren Pharmaceuticals into a late-stage trial following promising Phase 2 results of the potential Rett syndrome... Read more »
It was no easy task. After an extensive review of the many nominees for the first-ever Xconomy Awards San Diego, Xconomy editors across the country and a panel of local experts... Read more »
Celgene said Monday it has again sent the FDA an application for approval of ozanimod, an experimental multiple sclerosis drug it added to its pipeline in 2015 as part of its... Read more »